Genetics of cisplatin ototoxicity: confirming the unexplained?
- PMID: 23872836
- DOI: 10.1038/clpt.2013.116
Genetics of cisplatin ototoxicity: confirming the unexplained?
Abstract
Replication of findings in clinical pharmacogenetic studies is essential but often neglected. The observation that TPMT and COMT genotypes, in combination with ABCC3 genotype, are predictive of ototoxicity following cisplatin treatment has been confirmed. However, translating this observation into a useful preventive strategy requires more mechanistic insight.
Comment in
-
Evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity.Clin Pharmacol Ther. 2014 Aug;96(2):156-7. doi: 10.1038/clpt.2014.67. Epub 2014 Mar 18. Clin Pharmacol Ther. 2014. PMID: 24642735 No abstract available.
Comment on
-
Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children.Clin Pharmacol Ther. 2013 Aug;94(2):243-51. doi: 10.1038/clpt.2013.80. Epub 2013 Apr 10. Clin Pharmacol Ther. 2013. PMID: 23588304 Free PMC article.
-
The role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancer.Clin Pharmacol Ther. 2013 Aug;94(2):252-9. doi: 10.1038/clpt.2013.121. Epub 2013 Jun 11. Clin Pharmacol Ther. 2013. PMID: 23820299 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
